EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

Prognostic impact of systematic lymphadenectomy during interval debulking surgery after neoadjuvant chemotherapy in stage III ovarian cancer: A 38-institution retrospective cohort study using inverse probability of treatment weighting

Yuki Iida, Mayumi Kobayashi-Kato, Hisashi Noma, Tetsuro Shiraishi, Shogo Shigeta, Satoki Misaka, Akira Kikuchi, Yuko Mizunoe, Tomoko Yoshihama, Miho Suzuki, Yosuke Konno, Tsubasa Ito und 6 weitere

European Journal of Surgical Oncology · 2026-11 · 52 (11) · 112121

DOI: 10.1016/j.ejso.2026.112121 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Surgical Oncology, 2026-11. Verfasst von Yuki Iida und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Tottori University Faculty of Medicine, Yonago, Tottori, Japan. Electronic address: yiida19910623@gmail.com. Hauptthemen laut MEDLINE: Cytoreduction Surgical Procedures, Fallopian Tube Neoplasms, Lymph Node Excision, Ovarian Neoplasms. Die Arbeit nennt 32 Literaturangaben. Gefördert von: National Cancer Center Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: We evaluated the clinical significance of systematic lymph node dissection (SyLND) during interval debulking surgery (IDS) in patients with stage III ovarian cancer, focusing on subgroups that might benefit from SyLND. METHODS: The multicenter retrospective study included patients with FIGO stage III ovarian, fallopian tube, and primary peritoneal cancers, who underwent IDS following neoadjuvant chemotherapy (NACT), at Gynecologic Cancer Study Group of the Japan Clinical Oncology Group (JCOG-GCSG) institutions between 2017 and 2021. Patients were classified into SyLND and no/selective lymph node dissection (NoLND/SeLND) groups. Progression-free survival (PFS) was the primary outcome, and overall survival (OS) and postoperative complications were secondary outcomes. Inverse probability of treatment weighting was applied. RESULTS: Among 696 eligible patients, SyLND was associated with better PFS (hazard ratio [HR] 0.73, 95% confidence interval [CI] 0.55-0.97) and OS (HR 0.66, 95% CI 0.48-0.92) than NoLND/SeLND. In subgroup analyses of patients achieving complete resection, SyLND yielded no survival advantage in those with clinical-negative nodes (cN0). Conversely, among patients with clinical-positive nodes (cN1) before NACT, PFS and OS favored SyLND, although differences were not statistically significant. Similar trends were observed in cN1 patients whose lymph nodes decreased to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytoreduction Surgical ProceduresFallopian Tube NeoplasmsLymph Node ExcisionOvarian NeoplasmsPeritoneal NeoplasmsAgedFemaleHumansMiddle AgedChemotherapy, AdjuvantJapanLymphatic MetastasisNeoadjuvant TherapyNeoplasm StagingPostoperative ComplicationsPrognosisProgression-Free SurvivalRetrospective StudiesSurvival Rate

Stichwörter der Autor:innen

Interval debulking surgeryLymph node dissectionLymphadenectomyOvarian cancer

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Tottori University Faculty of Medicine, Yonago, Tottori, Japan. Electronic address: yiida19910623@gmail.com.
  • Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: maykobay@ncc.go.jp.
  • Department of Data Science, The Institute of Statistical Mathematics, Tokyo, Japan. Electronic address: noma@ism.ac.jp.
  • Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: teshirai@ncc.go.jp.
  • Department of Obstetrics and Gynecology, Tohoku University School of Medicine, Miyagi, Japan. Electronic address: shogo.shigeta.a4@tohoku.ac.jp.
  • Department of Gynecology, Shizuoka Cancer Center, Shizuoka, Japan. Electronic address: s.misaka@scchr.jp.

Förderung

  • National Cancer Center Japan

Zitieren

APA

Iida, Y., Kobayashi-Kato, M., Noma, H., Shiraishi, T., Shigeta, S., Misaka, S., Kikuchi, A., Mizunoe, Y., Yoshihama, T., Suzuki, M., Konno, Y., Ito, T., Togami, S., Komatsu, H., Ishikawa, M., Satoh, T., Watari, H., & Gynecologic Cancer Study Group of the Japan Clinical Oncology Group (2026). Prognostic impact of systematic lymphadenectomy during interval debulking surgery after neoadjuvant chemotherapy in stage III ovarian cancer: A 38-institution retrospective cohort study using inverse probability of treatment weighting. European Journal of Surgical Oncology, 52(11), 112121. https://doi.org/10.1016/j.ejso.2026.112121

Vancouver

Iida Y, Kobayashi-Kato M, Noma H, Shiraishi T, Shigeta S, Misaka S, et al. Prognostic impact of systematic lymphadenectomy during interval debulking surgery after neoadjuvant chemotherapy in stage III ovarian cancer: A 38-institution retrospective cohort study using inverse probability of treatment weighting. European Journal of Surgical Oncology. 2026;52(11):112121. doi:10.1016/j.ejso.2026.112121

BibTeX
@article{Iida2026,
  author = {Iida, Yuki and Kobayashi-Kato, Mayumi and Noma, Hisashi and Shiraishi, Tetsuro and Shigeta, Shogo and Misaka, Satoki and Kikuchi, Akira and Mizunoe, Yuko and Yoshihama, Tomoko and Suzuki, Miho and Konno, Yosuke and Ito, Tsubasa and Togami, Shinichi and Komatsu, Hiroaki and Ishikawa, Mitsuya and Satoh, Toyomi and Watari, Hidemichi and Gynecologic Cancer Study Group of the Japan Clinical Oncology Group, Gynecologic Cancer Study Group of the Japan Clinical Oncology Group},
  title = {Prognostic impact of systematic lymphadenectomy during interval debulking surgery after neoadjuvant chemotherapy in stage III ovarian cancer: A 38-institution retrospective cohort study using inverse probability of treatment weighting},
  journal = {European Journal of Surgical Oncology},
  year = {2026},
  volume = {52},
  number = {11},
  pages = {112121},
  doi = {10.1016/j.ejso.2026.112121}
}
Kostenlos starten →